Insmed (INSM) +26.3% after announcing the FDA has lifted the clinical hold previously placed on...

|By:, SA News Editor

Insmed (INSM) +26.3% after announcing the FDA has lifted the clinical hold previously placed on the company's Arikace drug for treating lung infections. The company says it continues discussions with the FDA on the remaining hold on the drug in the treatment of cystic fibrosis patients.